Centessa Pharmaceuticals (STU:260) Accumulated Depreciation : €-0.51 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Centessa Pharmaceuticals Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Centessa Pharmaceuticals's quarterly accumulated depreciation increased from Sep. 2023 (€-0.35 Mil) to Dec. 2023 (€-0.42 Mil) and increased from Dec. 2023 (€-0.42 Mil) to Mar. 2024 (€-0.51 Mil).

Centessa Pharmaceuticals's annual accumulated depreciation increased from Dec. 2021 (€-0.03 Mil) to Dec. 2022 (€-0.16 Mil) and increased from Dec. 2022 (€-0.16 Mil) to Dec. 2023 (€-0.42 Mil).

Centessa Pharmaceuticals Accumulated Depreciation Historical Data

The historical data trend for Centessa Pharmaceuticals's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Centessa Pharmaceuticals Accumulated Depreciation Chart

Centessa Pharmaceuticals Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated Depreciation

-0.03

-0.16

-0.42

Centessa Pharmaceuticals Quarterly Data
	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accumulated Depreciation	Get a 7-Day Free Trial										-0.19	-0.26	-0.35	-0.42	-0.51

Centessa Pharmaceuticals Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Centessa Pharmaceuticals Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Centessa Pharmaceuticals's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Centessa Pharmaceuticals (STU:260) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Centessa Pharmaceuticals PLC (STU:260) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

CNTA:USA

Address

1 Ashley Road, 3rd Floor, Altrincham, Cheshire, GBR, WA14 2DT

Website

https://www.centessa.com

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.

Centessa Pharmaceuticals (STU:260) Headlines

No Headlines